These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 23669885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
    Lip GYH, Haguenoer K, Saint-Etienne C, Fauchier L.
    Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
    [Abstract] [Full Text] [Related]

  • 3. Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
    Lip GY, Waldo AL, Ip J, Martin DT, Bersohn MM, Choucair WK, Akar JG, Wathen M, Halperin JL, IMPACT Investigators.
    Am J Cardiol; 2016 Dec 01; 118(11):1680-1684. PubMed ID: 27665206
    [Abstract] [Full Text] [Related]

  • 4. Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.
    Williams BA, Evans MA, Honushefsky AM, Berger PB.
    J Am Heart Assoc; 2017 Oct 12; 6(10):. PubMed ID: 29025746
    [Abstract] [Full Text] [Related]

  • 5. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
    Singer DE, Hellkamp AS, Piccini JP, Mahaffey KW, Lokhnygina Y, Pan G, Halperin JL, Becker RC, Breithardt G, Hankey GJ, Hacke W, Nessel CC, Patel MR, Califf RM, Fox KA, ROCKET AF Investigators.
    J Am Heart Assoc; 2013 Feb 19; 2(1):e000067. PubMed ID: 23525418
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
    Turk UO, Tuncer E, Alioglu E, Yuksel K, Pekel N, Ozpelit E, Vuran O, Tengiz I.
    Cardiol J; 2015 Feb 19; 22(5):567-75. PubMed ID: 26100825
    [Abstract] [Full Text] [Related]

  • 8. Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
    Lip GYH, Al-Saady N, Jin J, Sun M, Melino M, Winters SM, Zamoryakhin D, Goette A.
    Am J Cardiol; 2017 Sep 01; 120(5):792-796. PubMed ID: 28709650
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T, Kaneko H, Mishina S, Wang F, Morita S.
    J Stroke Cerebrovasc Dis; 2017 Oct 01; 26(10):2102-2110. PubMed ID: 28532651
    [Abstract] [Full Text] [Related]

  • 11. Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study.
    Li Y, Yu J, Kuang Y, Wu C, Yang L, Fang Q, Pei Q, Yang G.
    Curr Med Res Opin; 2020 Sep 01; 36(9):1433-1439. PubMed ID: 32677855
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment.
    Gorzelak-Pabiś P, Zyzak S, Krewko Ł, Broncel M.
    Pol Arch Med Wewn; 2016 Aug 09; 126(7-8):494-501. PubMed ID: 27511466
    [Abstract] [Full Text] [Related]

  • 17. The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis.
    Vestergaard AS, Skjøth F, Larsen TB, Ehlers LH.
    PLoS One; 2017 Aug 09; 12(11):e0188482. PubMed ID: 29155884
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.